EUVIMEDEUVIMED entdecken
Crossref

L26/P-711 Does Timing Matter? Impact of the Time Interval Between AMH Measurement and Ovarian Stimulation on Oocyte Yield Prediction

L. Melado Vidales, B. Lawrenz, D. Hamidreza, D.G. Raquel, R. Francisco, M. Laura, S. Sahra, B. Asina, A. Andrea, E. Ibrahim, F. Human

Human Reproduction · 01.07.2026 · 41 (Supplement_1)

DOI: 10.1093/humrep/deag083.1040 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von L. Melado Vidales und 10 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study question Does the interval between AMH measurement and ovarian stimulation (OS), as well as the cycle phase at the time of AMH measurement, affect the accuracy of oocyte prediction? Summary answer A prolonged interval between AMH-measurement and OS results in a slight overprediction of oocyte yield. The menstrual phase does not affect oocyte prediction. What is known already AMH is one of the most reliable markers of ovarian reserve. In OS for IVF/ICSI treatment, AMH is frequently used to tailor gonadotropin dosages and predict oocyte yield. AMH levels not only decline with age in females but also exhibit short-term biological variation across and between cycles. In routine clinical practice, AMH is often measured once and reused for subsequent ovarian stimulation cycles to reduce patient burden. However, the extent to which the time interval between AMH measurement and stimulation start, as well as the menstrual phase at sampling, affects the accuracy of oocyte prediction remains insufficiently defined. Study design, size, duration Retrospective analysis of 3,060 OS cycles from 2,169 women, performed in a tertiary infertility center between January 2016 and November 2024. AMH measurements were performed using the Elecsys AMH immunoassay. Blood samples for AMH measurement were obtained either 1-30 / 31-90 or 91-180 days before the start of the OS. Participants/materials, setting, methods Women who underwent an IVF/ICSI treatment due to primary or secondary infertility. OS were performed with standard protocols (GnRH-antagonist and progestine-primed ovarian stimulation protocols). Final oocyte maturation was achieved using either hCG alone, dual trigger (hCG plus GnRH-agonist), or GnRH-agonist alone in high-responder patients. The oocyte-retrieval procedure was performed 34 to 36 hours later. Main results and the role of chance A total of 3,060 OS cycles were included (median age 36 years [IQR 32–41], BMI 27.8 kg/m² [24.6–30.8], AMH 1.43 ng/mL [0.59–2.88], AFC 10 [5–16]). AMH was measured on the same day in 21.4% of cycles, within 1–30 days in 33.0%, within 31–90 days in 26.6%, and within 91–180 days in 18.9%. Oocyte counts were overdispersed; therefore, negative binomial regression models were used. For both cumulus–oocyte complexes (COC) and mature oocytes (MII), models combining AMH and AFC showed the best fit. Overall predictive accuracy remained similar across all AMH–stimulation lag categories (MdAPE 34.7–37.1% for COC; 37.4–41.3% for MII), with no abrupt deterioration up to 6 months. Calibration shifted modestly with longer lag: median relative bias for COC changed from −4.8% (same day) to − 11.8% (91–180 days), and for MII from −2.5% to − 14.3%, indicating a gradual tendency toward overprediction as AMH measurements became older. This was supported by a small but statistically significant AMH×lag interaction (χ²=8.43, p=0.038), consistent with mild attenuation rather than loss of predictive performance. In cycles with lag ≤30 days (n = 1,666), AMH’s association with oocyte yield was comparable across luteal, periovulatory, and follicular phase measurements (interaction p=0.085 for COC; p=0.324 for MII). Limitations, reasons for caution The retrospective design of the study is a limitation, as well as the different OS stimulation protocols. Wider implications of the findings The reliability of AMH measurement for oocyte prediction remains almost stable for up to 180 days, and the cycle phase at the time of measurement does not influence the results. Consequently, repeated AMH measurements for oocyte prediction during this timeframe appear unnecessary, thereby reducing patient burden. Trial registration number No

Zitieren

APA

Vidales, L. M., Lawrenz, B., Hamidreza, D., Raquel, D., Francisco, R., Laura, M., Sahra, S., Asina, B., Andrea, A., Ibrahim, E., & Human, F. (2026). L26/P-711 Does Timing Matter? Impact of the Time Interval Between AMH Measurement and Ovarian Stimulation on Oocyte Yield Prediction. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.1040

Vancouver

Vidales LM, Lawrenz B, Hamidreza D, Raquel D, Francisco R, Laura M, et al. L26/P-711 Does Timing Matter? Impact of the Time Interval Between AMH Measurement and Ovarian Stimulation on Oocyte Yield Prediction. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.1040

BibTeX
@article{Vidales2026,
  author = {Vidales, L. Melado and Lawrenz, B. and Hamidreza, D. and Raquel, D.G. and Francisco, R. and Laura, M. and Sahra, S. and Asina, B. and Andrea, A. and Ibrahim, E. and Human, F.},
  title = {L26/P-711 Does Timing Matter? Impact of the Time Interval Between AMH Measurement and Ovarian Stimulation on Oocyte Yield Prediction},
  journal = {Human Reproduction},
  year = {2026},
  volume = {41},
  number = {Supplement_1},
  doi = {10.1093/humrep/deag083.1040}
}
Kostenlos starten →